Unicycive Therapeutics, Inc.
UNCY
$5.12
$0.091.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.83% | -162.88% | 27.70% | -45.26% | -35.54% |
| Total Depreciation and Amortization | 24.72% | 132.26% | 33.64% | 47.61% | 59.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.16% | 216.78% | -92.40% | 284.18% | 304.84% |
| Change in Net Operating Assets | 70.79% | 19.77% | -1,294.38% | -117.46% | -291.73% |
| Cash from Operations | 15.95% | 7.63% | -9.60% | -12.72% | -53.09% |
| Capital Expenditure | 86.76% | 80.49% | 66.67% | 8.00% | -161.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25,269.12% | -20,917.07% | -16,698.61% | 8.00% | -161.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 366.26% | 1,784.88% | 6,939.24% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | 100.00% |
| Other Financing Activities | -94.55% | -353.10% | 64.22% | 60.72% | 75.12% |
| Cash from Financing | 387.32% | 3,167.68% | 3.06% | -9.64% | -69.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 212.36% | 160.36% | -81.41% | -42.52% | -184.72% |